CCL5 and ovarian carcinoma: Induces apoptosis in ovarian cancer cells through caspase- and ROS-dependent pathways; reduces recruitment of TAMs by inhibiting chemokines MCP-1 and RANTES; suppresses M2 polarization of TAMs and reduces cancer-promoting factors like MMP-2, MMP-9, and VEGF.